Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of atomoxetine in reducing the symptoms of
attention deficit hyperactivity disorder (ADHD) in young children.